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Rodriguez-Tapia E, Perez-Medina A, Bian X, Galligan JJ. Upregulation of L-type calcium channels in colonic inhibitory motoneurons of P/Q-type calcium channel-deficient mice. Am J Physiol Gastrointest Liver Physiol 311: G763-G774, 2016. First published September 1, 2016; doi:10.1152/ajpgi.00263.2016.-Enteric inhibitory motoneurons use nitric oxide and a purine neurotransmitter to relax gastrointestinal smooth muscle. Enteric P/Q-type Ca 2ϩ channels contribute to excitatory neuromuscular transmission; their contribution to inhibitory transmission is less clear. We used the colon from tottering mice (tg/tg, loss of function mutation in the ␣1A poreforming subunit of P/Q-type Ca 2ϩ channels) to test the hypothesis that P/Q-type Ca 2ϩ channels contribute to inhibitory neuromuscular transmission and colonic propulsive motility. Fecal pellet output in vivo and the colonic migrating motor complex (ex vivo) were measured. Neurogenic circular muscle relaxations and inhibitory junction potentials (IJPs) were also measured ex vivo. Colonic propulsive motility in vivo and ex vivo was impaired in tg/tg mice. IJPs were either unchanged or somewhat larger in tissues from tg/tg compared with wild-type (WT) mice. Nifedipine (L-type Ca 2ϩ channel antagonist) inhibited IJPs by 35 and 14% in tissues from tg/tg and WT mice, respectively. The contribution of N-and R-type channels to neuromuscular transmission was larger in tissues from tg/tg compared with WT mice. The resting membrane potential of circular muscle cells was similar in tissues from tg/tg and WT mice. Neurogenic relaxations of circular muscle from tg/tg and WT mice were similar. These results demonstrate that a functional deficit in P/Q-type channels does not alter propulsive colonic motility. Myenteric neuron L-type Ca 2ϩ channel function increases to compensate for loss of functional P/Q-type Ca 2ϩ channels. This compensation maintains inhibitory neuromuscular transmission and normal colonic motility. myenteric plexus; Ca 2ϩ channel mutations; neuromuscular transmission
NEW & NOTEWORTHY

P/Q-type Ca 2ϩ channels contribute to neurotransmission in the gut. Tottering mice (tg/tg) have a loss of function mutation in the gene encoding P/Q-type Ca 2ϩ channels. Colonic motility and inhibitory neuromuscular neurotransmission are similar in wild-type and tg/tg mice. This is associated with upregulation of L-type Ca 2ϩ channel function in colonic myenteric neurons in tg/tg mice. These data demonstrate that the enteric nervous system adapts to ion channel gene mutations to maintain normal gut function.
GASTROINTESTINAL (GI) motility is controlled partly by the activity of enteric excitatory and inhibitory motoneurons (7, 62) . Inhibitory neuromuscular transmission causes membrane hyperpolarization and relaxation of smooth muscle. Inhibitory neuromuscular transmission is mediated largely by nitric oxide (NO) (55) and one or more purines including ATP and ␤-NAD and their metabolites (30, 44, 73) . In addition, vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide contribute to inhibitory neuromuscular transmission (12, 56) . Inhibitory neuromuscular transmission is essential for producing propulsive motility patterns (30) .
Inhibitory neuromuscular transmission to colonic circular muscle produces a biphasic postjunctional electrical response (23, 30, 31) . The first phase is a rapid membrane potential hyperpolarization known as the fast inhibitory junction potential (IJP). The fast IJP is mediated by a purinergic neurotransmitter acting at postjunctional G protein-coupled P2Y 1 receptors (23) . Activation of muscle P2Y 1 receptors causes an increase in intracellular Ca 2ϩ that causes opening of smallconductance Ca 2ϩ -activated K ϩ channels (33) . The second component consists of a smaller amplitude but longer lasting slow IJP mediated by NO (56) . Release of these inhibitory neurotransmitters is Ca 2ϩ dependent and consequently regulated by activation of voltage-gated calcium channels (VGCC) (6, 24) .
In smooth muscle, NO activates guanylate cyclase (GC) and protein kinase G (PKG), which modulates myosin light chain kinase activity responsible for smooth muscle contraction. In addition, PKG can phosphorylate and open K ϩ channels to produce smooth muscle membrane hyperpolarization (43, 54) . It has been shown that slow IJPs are mediated by direct action of NO on smooth muscle cells and on interstitial cells of Cajal (ICCs). Studies done in smooth muscle-specific GC-knockout (KO) mice showed reduced IJP duration whereas in ICC-GCspecific KO mice the IJP was reduced in amplitude (40) . Cell type-specific GCs also mediate the actions of NO on contractile activity in the mouse colon. Basal release of NO regulates spontaneous contractile activity via an action on ICC-GC while the contractile effects of higher levels of NO that occur during nerve stimulation are mediated via direct action on smooth muscle cells (41) .
Influx of Ca 2ϩ through nerve terminal VGCCs triggers neurotransmitter release from nerve terminals (1) . The pore of VGCCs is formed by different ␣-subunits and VGCC diversity is due to expression of multiple genes encoding different ␣-subunit subtypes. Pharmacological and electrophysiological studies showed there are at least five main ␣-subunits for high-voltage-activated Ca 2ϩ channels. The pores of P/Q-type (Cav2.1), N-type (Cav2.2), and R-type (Cav2.3) channels are formed by the ␣1A, ␣1B, and ␣1E subunits, respectively. L-type (Cav1.2-1.3) Ca 2ϩ channels are formed by the ␣1C, ␣1D, ␣1S, and ␣1F subunits (63, 74) .
The contributions of N-and P/Q-type Ca 2ϩ channels to excitatory neuromuscular transmission in the peripheral ner-vous system are well established (65) . However, the contribution of different VGCC subtypes during inhibitory neuromuscular transmission in the gut is not as clear. Identification of the VGCC subtypes involved in enteric inhibitory neuromuscular transmission should provide a better understanding of the neuronal circuitry controlling GI motility and might also reveal new drug targets for the treatment of GI motility disorders.
In humans, mutations in the Cav2.1 (P/Q-type VGCC) gene cause channelopathies and neurological disorders (5, 50) including episodic ataxia type-2 and autosomal dominant spinocerebellar ataxia type-6, which result in disruption of voluntary motor coordination and balance (48, 75) . Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune condition in which the autoantibodies are generated against somatic motor nerve terminal VGCCs causing skeletal muscle weakness (36) . LEMS is also associated with disruption of autonomic neurotransmission with constipation being a common symptom of LEMS (29, 66) .
Several spontaneous mutations of the P/Q-type channel have been identified in mice and one of them is the tottering (tg/tg) mutant mouse. The tg/tg mutation encodes for a prolineleucine amino acid substitution in the S4 -S5 linker region of domain II of the ␣1A subunit (18) . The point mutation near the pore-forming domain of the channel results in a decrease in whole cell current density and voltage-dependent inactivation during prolonged hyperpolarization in cerebellar Purkinje cells (64) . These changes occur without altering the single channel properties and conductance of P/Q-type VGCC. The tg/tg mice express a phenotype characterized by ataxia, episodes of behavioral arrest, and motor seizures (26, 45) . Synaptic plasticity involving VGCC has been demonstrated at multiple tg/tg synapses. For example, synaptic transmission in the cerebellum and hippocampus is maintained due to an increase in the contribution of N-type VGCC to synaptic transmission (38, 50) . Skeletal neuromuscular transmission in tg/tg mice is sustained by an upregulation in the contribution of both N-and R-type VGCCs (47) . Whole cell Ca 2ϩ currents recorded from basal forebrain neurons from tg/tg mice are unaltered due to a functional upregulation of L-type VGCCs (17) . These studies demonstrate the capacity of the nervous system to respond to alterations in VGCC function or expression and the importance of functional redundancy or plasticity of Ca 2ϩ channel expression in the nervous system. By using the tg/tg mouse as an animal model we sought to determine the functional consequences of a loss-of-function of P/Q-type VGCCs on enteric neuromuscular transmission and colonic propulsive motility. In addition, we aimed to investigate whether a functional deficit in P/Q-type channels would unmask compensatory mechanisms involving other VGCC subtypes in the enteric nervous system (ENS).
MATERIALS AND METHODS
Mice. All animal use protocols were approved by the Institutional Animal Care and Use Committee at Michigan State University. Breeding pairs of heterozygote C57BL/6J-tg mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Litters were genotyped at weaning, which occurred 3 wk after birth. Homozygote tg/tg mice were also identified by their characteristic phenotype consisting of ataxia, motor seizures, and episodes of behavioral arrest. All mice were fed a standard chow diet and were studied between 4 and 5 mo of age. Male mice only were used in these studies. Mice were euthanized with isoflurane anesthesia followed by cervical dislocation.
Propulsive colonic motility studies in vivo. Fecal pellet output was evaluated in wild-type (WT) and tg/tg mice. Mice were individually housed with a premeasured amount of food and water. The cages were equipped with the normal bedding material to minimize stress. Fecal output was collected for 48 h and then pellets were counted and weighed. Fecal pellets were then placed into a 60°C oven overnight and dry weight was measured the following morning.
Colonic migrating motor complex. Preparation of colonic segments for recording the colonic migrating motor complex (CMMC) was performed as described previously (14, 60) . Briefly, after the mice were euthanized the colon was removed and placed into oxygenated and warm (37°C) Krebs solution. Luminal content was gently flushed out with Krebs solution and a stainless steel rod was inserted into the lumen and the tissue was secured at each end with a surgical silk. Metal clips (Fine Science Tools, Foster City, CA) were attached to the oral and anal end of the tissue 1.5 cm apart. Both metal clips were then connected to separate force transducers using surgical silk. The rod holding the tissue was secured in a 60-ml bath containing oxygenated and prewarmed Krebs solution at 37°C. The oral and anal ends of the colon were stretched to an initial tension of 1 g. The tissue was allowed to equilibrate for 30 min during which a regular pattern of propagating contractions known as the CMMC was established. CMMCs were recorded for an additional hour and a 30-min segment of the recording was selected for analysis. Frequency, amplitude, and area under the curve (AUC) of contractions were measured at the oral and anal recording sites. Propagated CMMCs were identified as a complex in which a contraction occurred first at the oral recording site followed by a contraction recorded at the anal site with a latency of 7.5 s (mouse colon CMMC propagation speed ϭ ϳ2 mm/s). Recordings were obtained by using two Grass Instruments CP122A strain gauge amplifiers. The output of these amplifiers was fed to an analog/digital converter (Minidigi 1A, Molecular Devices; Sunnyvale, CA) and LabChart software 7 (AD Instruments, Colorado Springs, CO).
Intracellular recordings of IJPs and smooth muscle membrane potential. Conventional intracellular electrophysiological techniques were used to record IJPs and membrane potential in the distal colon of WT and tg/tg mice. A 2-cm segment of the distal colon was harvested from the mice immediately after euthanasia and placed in a petri dish containing prewarmed (37°C) and oxygenated (95% O 2-5% CO2) Krebs solution. The Krebs solution contained scopolamine (1 M) to block muscarinic receptors, and in some experimental conditions nifedipine (1 M) was added to block L-type Ca 2ϩ channels. The colonic segment was cut open along the mesenteric border and pinned flat on the petri dish with the mucosal layer facing upward. The mucosa and submucosa layers were gently removed with fine forceps. A 5-mm 2 section was cut and transferred to a 5-ml silicone elastomerlined recording chamber. The section was stretched lightly and pinned to the chamber floor with small stainless steel pins. The chamber was mounted on a stage of an inverted microscope and it was then perfused with oxygenated Krebs solution at a flow rate of 5 ml/min. The preparations were equilibrated for 30 min.
Smooth muscle cells were impaled with glass microelectrodes (Frederick-Haer, Brunswick, ME) filled with 2 M KCl and with a tip resistance of 60 -100 M⍀. To avoid muscle movement in experimental conditions when nifedipine was absent, a small square of tissues was immobilized using micro-pins (0.125-mm diameter, World Precision Instruments). This technique minimized muscle movement making impalements of 2-60 min duration possible. Upon successful impalement the resting membrane potential of circular muscle cells was allowed to stabilize for 2 min. Membrane potential was recorded with an Axoclamp 2A amplifier, a Digidata 1322A analog-digital converter, and Axoscope 9.2 software (all from Molecular Devices, Sunnyvale, CA). Amplified signals were sampled at 2 kHz and filtered at 1 kHz. Data were stored on a computer hard drive and Clampfit 10.3 software was used for data analysis.
IJPs were evoked by using a pair of Ag/AgCl wire electrodes (1-mm diameter, A-M Systems, Seattle, WA) inserted into the recording chamber parallel to the circular muscle fibers to electrically stimulate the nerve fibers supplying the muscle cells. Electrical stimuli consisted of 1-s train duration, 0.8-ms pulse duration, 10 Hz, and 10 -90 V provided by a Grass Instruments S88 stimulator and stimulus isolator constant current unit (Grass Technologies, West Warwick, RI). We measured the peak IJP amplitude the AUC of the IJP.
Drug application. Two types of drug application systems were used to study drug effects on IJPs. In one application system, drugs were added in known concentrations to the flowing Krebs solution by a system of three-way stopcocks. Drug concentrations reached steady state in the recording chamber within 4 min. The second system applied drugs locally using a quartz glass tube (30 -40 m tip diameter) placed within 50 -150 m of the impaled muscle cell. Before impalement, Krebs solution was superfused through the quartz micropipette near the recording microelectrode to prevent disruption of membrane potential recordings by turning on of the local application system. After recording control IJPs, drug-containing solution was applied by using a VC-8 valve controller system (Warner Instruments, Hamden, CT). The impaled muscle cells were exposed to drug treatments for at least 5 min before responses were recorded.
Nerve-evoked mechanical responses in colonic circular muscle rings. The distal colon of WT and tg/tg mice was dissected into 1-cm-long circular muscle rings. Each segment was mounted with silk ligatures between a platinum foil electrode and a stationary hook connected to an isometric force transducer (FT03C, Grass Instruments) and placed in a 20-ml jacketed organ bath containing oxygenated Krebs solution at 37°C. A resting tension of 1 g was applied to each preparation and then tissues were allowed to equilibrate for 30 min. During this time the tissues were washed with fresh Krebs solution at 10 min intervals and tension was reestablished to 1 g if necessary. After equilibration, bethanechol (10 M), muscarinic receptor agonist, and sodium nitroprusside (SNP; 5 M), a nitric oxide donor, were applied to each bath to produce maximal contractions and relaxations, respectively. The peak amplitude of these responses was used to normalize the nerve-mediated contractions and relaxations. From this point on, scopolamine (1 M) was added to all baths to record noncholinergic inhibitory neuromuscular transmission.
Contractions and relaxations were induced by transmural electrical stimuli (20 mA, 0.1-ms pulse duration, 1-to 25-Hz stimulus trains). Trains of nerve stimulation were applied at 2-min intervals and applied to each tissue twice. Responses induced by the second frequency response curve were used for analysis. Tetrodotoxin (TTX; 0.3 M) was used to demonstrate the neurogenic origin of the contractions and relaxations. MRS 2179 (10 M, P2Y 1 receptor antagonist) and -nitro-L-arginine (NLA; 100 M, nitric oxide synthase inhibitor) were used to study purinergic and nitrergic signaling. Each drug was applied for 10 min before frequency response curves were obtained in each tissue. Transmural electrical stimuli were provided by a Grass S48 stimulator and mechanical activity of the muscle rings was recorded with Labscribe (iWorx, Dover, NH) and a computer.
We measured the peak amplitude of contractions and relaxations and normalized these values to using the peak amplitude of bethanechol-induced contraction or the peak amplitude of the SNPinduced relaxation in the same tissues.
Drugs. Nifedipine, scopolamine, -conotoxin-GVIA (-CTX-GVIA), -agatoxin-IVA (-ATX-IVA), SNX-482, TTX, NLA, SNP, bethanechol, and MRS 2179 were obtained from Sigma-Aldrich. All drugs were diluted in deionized water except for L-NNA, which was dissolved in 0.1 N HCl, and nifedipine, which was dissolved in DMSO.
Statistical analysis. Data are presented as means Ϯ SE with n values being the number of mice for in vivo studies, in vitro CMMC studies, and circular muscle ring contraction-relaxation studies. For intracellular recording studies the n value represents the number of cells. Statistical differences between groups were analyzed with a two-way ANOVA followed by a Bonferroni post hoc test or when applicable a two-tailed Student's t-test was used. P Ͻ 0.05 was the criterion for determining statistical significance.
RESULTS
Colonic motility is altered in tg/tg mice. WT mice (35.9 Ϯ 2.5 g) weighed more than tg/tg mice (21.5 Ϯ 0.9 g; P Ͻ 0.05) at 3 mo of age. Water intake over 48 h by tg/tg mice (14 Ϯ 0.9 ml) was significantly less than for WT mice (20 Ϯ 1 ml, P Ͻ 0.05). Food intake was not different between WT and tg/tg mice. The tg/tg mice showed a small but statistically significant decrease in the number of fecal pellets produced in a 48-h period (Fig. 1A) . There was no difference in fecal pellet weight between WT and tg/tg mice (Fig. 1B) . The percent of fecal output was calculated by dividing the total dry weight of the collected fecal material into the total food intake for the 48-h period. Although the results showed a modest decrease in this ratio for tg/tg mice, the percent fecal output was not different between WT and tg/tg mice (Fig. 1C) .
The CMMC is a motor pattern of propagating contractions that occurs in the mouse colon ex vivo (56, 60, 61) (Fig. 2, A  and B) . In the colon from WT mice, 88 Ϯ 4% of the contractions that began at the oral recording site appeared to form a continuous propagating contraction that was also recorded at the anal recording site after a relatively constant latency. For purposes of this study we have defined these temporally linked contraction as propagating contractions. In the colon from tg/tg mice, 94 Ϯ 2.5% of the contractions that appeared to start at the oral site were also temporally linked to contractions re- corded at the anal site. Contractions occurring only at oral site were identified in 5.5 Ϯ 3.6 and 5.3 Ϯ 2.4% of the total contractions observed in WT and tg/tg mice, respectively. Contractions occurring only at the anal side were never observed in WT or tg/tg mice (data not shown). There was a tendency for the AUC of the oral and anal contractions to be larger in tg/tg mice. However, this increase was only significant for the AUC of anal contractions in tg/tg mice (Fig. 2, C  and D) . These data show that ex vivo propulsive motility is similar in colon segments from WT and tg/tg mice.
Increased IJP amplitude in circular muscle cells from tg/tg mice. The resting membrane potential of circular muscle smooth muscle cells did not differ between WT (Ϫ44 Ϯ 0.9 mV, n ϭ 20 cells, n ϭ 5 mice) and tg/tg mice (Ϫ44 Ϯ 0.7 mV, n ϭ 20 cells, n ϭ 5 mice; P Ͼ 0.05). To determine whether P/Q-type VGCCs were required for inhibitory neuromuscular transmission we measured IJPs in colon segments from WT and tg/tg mice (Fig. 3A) . IJPs were recorded in the absence of the L-type VGCC blocker nifedipine (1 M) to unmask any potential role of these channels in IJP generation. We found a significant increase in the amplitude but not the AUC of the IJPs recorded in tissues from tg/tg mice compared with WT mice (Fig. 3, B and C) . These data show an increase in IJP amplitude despite the loss-of-function of P/Q-type VGCCs in tg/tg mice.
Purinergic and nitrergic components of the IJP in the colon from tg/tg mice. The P2Y 1 receptor antagonist MRS 2179 (10 M) blocked the fast IJP in tissues from WT (Fig. 4A) and tg/tg (Fig. 4B) mice, confirming that this is a purinergic response. In tissues from WT mice, MRS 2179 reduced the AUC of the IJP but this was not statistically different from control IJPs (Fig. 4C) . MRS 2179 produced a statistically significant decrease in the AUC of the IJP in tg/tg mice (Fig.  4D ). In the presence of MRS 2179, the remaining nitrergic component of the IJP was similar in amplitude in tissues from WT and tg/tg mice (Fig. 4E) . The NOS inhibitor L-NNA (100 M) reduced but did not block IJPs in tissues from WT (Fig.  5, A and C) and tg/tg mice (Fig. 5, B and D) . In the presence of L-NNA, the purinergic component was isolated and the AUC of this component was not different between tg/tg and WT mice (Fig. 5E) .
Nifedipine inhibits IJPs in the colon of tg/tg mice. The results showing an increase in the IJP in tissues from tg/tg mice suggest that a compensatory adaptation occurred to maintain inhibitory neuromuscular transmission in the colon of these mice. To identify potential adaptive mechanisms, IJPs were studied in the presence of the L-type VGCC blocker nifedipine (1 M). The resting membrane potential of smooth muscle cells in the colon of WT and tg/tg mice was not different (Fig. 6A) indicating smooth muscle L-type VGCC expression or function was not affected by the tg/tg mutation. When nifedipine was present, IJP amplitude and AUC were reduced in tissues from tg/tg mice (Fig. 6, B-D) . To further investigate the effect of nifedipine, the IJPs recorded in the absence and in the presence of nifedipine were grouped and compared in tissues from tg/tg and WT mice (Fig. 7, A and B) . Nifedipine produced a significantly greater inhibition of IJP amplitude (Fig. 7C) and AUC (Fig. 7D) in tissues from tg/tg compared with WT mice. 
Multiple VGCC subtypes contribute to IJPs in WT and tg/tg mice. Since a significant portion of the IJP requires L-type
VGCCs in the colon of tg/tg mice, we tested the contribution of other VGCCs using subtype-specific blockers. Blocking P/Qtype VGCCs with -ATX-IVA (0.1 M) reduced the IJP by 41% in tissues from WT mice but the IJP was reduced by only 3% tissues from tg/tg mice (Fig. 8A) . The R-type VGCC blocker, SNX-482 (0.1 M) reduced the IJP by 36 and 52% in tissues from WT and tg/tg mice, respectively (Fig. 8B) . The N-type VGCC blocker -CTX-GVIA (0.1 M) reduced the IJP by 47% tissues from WT mice and by 61% in tissues from tg/tg mice (Fig. 8C) .
Neurogenic circular muscle relaxations were not altered in tissues from tg/tg mice. We next studied nerve-mediated relaxation of circular muscle rings. SNP (5 M) produced similar relaxations in tissues from WT and tg/tg mice and we used this response to normalize the peak amplitude of neurogenic relaxations. There was a frequency-dependent increase in relaxation amplitude that was similar in tissues from WT and tg/tg mice (Fig. 9, A and B) . Inhibiting NOS with NLA (100 M) significantly reduced neurogenic relaxations recorded from WT and tg/tg circular muscle rings (Fig. 10, A and B) . Blocking the purinergic P2Y 1 receptor with MRS 2179 (10 M) did not inhibit relaxations in tissues from WT mice (Fig. 10C) . However, in tissues from tg/tg mice, ANOVA revealed that MRS 2179 produced an overall difference in the frequency response curve compared with control (P Ͻ 0.05), but there were no significant differences between responses at each stimulation frequency (Fig. 10D) . We next compared the amplitude of neurogenic relaxations in circular muscle rings from WT and tg/tg mice. We found no difference in the purinergic relaxation (NLA, 100 M present) in tissues from WT and tg/tg mice (Fig. 11A) . Overall, ANOVA revealed that the nitrergic component (MRS 2179, 10 M present) of the relaxation was reduced in tissues from tg/tg mice (P Ͻ 0.05) but there were no significant differences at individual stimulation frequencies (Fig. 11B) . ATP-induced (Fig. 11C ) and SNP-induced (Fig. 11D ) circular muscle relaxations were not different in tissues from WT and tg/tg mice.
DISCUSSION
These studies investigated the functional consequences of the tg/tg mutation (loss-of-function in P/Q-type VGCCs) in enteric inhibitory neuromuscular transmission. Specifically, we tested the hypothesis that loss-of-function in P/Q-type VGCCs would disrupt enteric inhibitory neuromuscular transmission and colonic propulsive motility. We found that, despite a substantial functional deficit in P/Q-type VGCCs, colonic propulsive motility in vivo and ex vivo were largely unchanged despite a small but significant reduction in the number of fecal pellets expelled in tg/tg mice. We also found that inhibitory neuromuscular transmission and neurogenic circular muscle relaxations were unaffected by the tg/tg mutation. Colonic motor function due to a compensatory contribution of L-type VGCCs to inhibitory neuromuscular transmission was maintained.
P/Q-type VGCCs contribute to inhibitory neuromuscular transmission to the colon. P/Q-type VGCCs are expressed throughout the nervous system where they contribute to control of neuronal excitability and neurotransmitter release (9, 16, 69) . Disruption of P/Q-type channel function occurs in a number of channelopathies including familial hemiplegic migraine, episodic ataxia type-2, and autosomal dominant spinocerebellar ataxia type-6 (46, 75) . These channelopathies present largely as somatic motor disorders but there are also autonomic (including enteric nervous system) consequences as well (66) . P/Q-type VGCCs contribute to excitatory neuromuscular transmission in the gut (3, 28, 65) and we found that -agatoxin-IVA, a P/Q channel blocker, inhibited (by ϳ40%) IJPs recorded from colonic circular muscle from WT mice. There may be species differences in VGCC subtypes contributing to inhibitory neuromuscular transmission in the colon as IJPs recorded from circular muscle in the rat colon are resistant to blockade by -agatoxin-IVA (4).
GI smooth muscle IJPs are often recorded with L-type VGCC blockers in the physiological buffer solution to abolish muscle action potentials and muscle movement. However, under normal conditions L-type VGCC blockers do not alter active or passive properties of enteric neurons (34, 35) nor do they affect enteric neurotransmitter release (13, 42, 51, 52) . Thus adding nifedipine (L-type VGCC blocker) to physiological buffer would not alter IJPs in tissues from WT mice. However, we found that nifedipine produced a greater inhibition of colonic circular muscle IJPs in tissues from tg/tg compared with WT mice. These data suggest that in WT mice P/Q-type VGCCs contribute to regulation of release of the purinergic neurotransmitter and NOS activation to produce IJPs, while in tg/tg mice L-type VGCCs contribute to inhibitory neurotransmitter release. Nifedipine did not change the resting membrane potential of circular muscle cells in tissues from WT or tg/tg mice. This is noteworthy as the nitrergic component of ongoing inhibitory input to colonic muscle regulates resting membrane potential (25) . This result indicates that the nitrergic component of ongoing inhibitory neurotransmission to colon smooth muscle was unaffected by the tg/tg mutation.
Upregulation of L-type VGCCs in the colon of tg/tg mice. L-type VGCCs respond to functional perturbations against other calcium channel subtypes (17, 19, 72) . Therefore, we investigated whether the tg/tg mutation induces compensatory adaptations involving other VGCC subtypes. The first experiments that suggested a functional compensation in the contribution of L-type VGCCs to inhibitory neuromuscular transmission were IJP recordings in the absence and presence of nifedipine. IJPs recorded in tissues from tg/tg mice without nifedipine were larger than IJPs recorded in the presence of nifedipine. In issues from WT mice, IJPs recorded without nifedipine were modestly decreased compared with IJPs recorded in the presence of this drug. Blocking L-type VGCCs caused a 35% inhibition of the IJP in tissues from tg/tg mice while in tissues from WT mice it caused only 14% inhibition. This clearly shows that the IJP in tg/tg mice has greater nifedipine sensitivity compared with WT mice. The present study also showed a small increase in the sensitivity of the IJP in tissues from tg/tg mice to N-and R-type VGCC blockers. As expected, the IJP in tissues from tg/tg mice was unaffected by the P/Q channel blocker.
The increased contribution of L-type VGCCs results in normal IJP amplitudes and neurogenic circular muscle relaxation in the absence of functional P/Q-type VGCCs. A normal or even enhanced IJP in tg/tg mice would produce normal relaxation of circular muscle rings. Inhibitory neuromuscular transmission contributes to propulsive motility patterns throughout the gut. Therefore, upregulation of L-type VGCCs in tg/tg mice likely accounts for the normal fecal pellet output in vivo and CMMC ex vivo that we observed in this study.
Calcium channel plasticity in tg/tg mice. P/Q-type channels conduct 90% of the whole cell calcium current in cerebellar Purkinje neurons of WT mice (64) . In tg/tg mice there is a substantial decrease in the whole cell current recorded from these neurons without functional compensation via a contribution of other VGCC subtypes to whole cell currents (8, 64) . However, synaptic transmission in other cerebellar neurons and in hippocampal neurons of tg/tg mice is maintained due to an increased contribution of N-type VGCCs to neurotransmitter release (38, 50) . Although P/Q-type VGCC is the predominant calcium channel controlling acetylcholine release at the skeletal neuromuscular junction (NMJ), there are no major deficits in neuromuscular transmission in tg/tg mice (47, 49) . This is due to the fact that there is a compensatory contribution in the role of N-and R-type VGCCs in regulating acetylcholine release at the NMJ (47) . Basal forebrain neurons express the full complement of VGCCs (27) . Whole cell currents in basal forebrain neurons from tg/tg mice are maintained at normal levels and this is accomplished by an adaptive increase in current carried by L-type VGCCs (17) . Perturbations to P/Qtype VGCCs also occur in autoimmune disorders. In LEMS, autoantibodies bind to P/Q-type VGCCs decreasing their function and expression at the NMJ (36, 37) . However, neuromuscular transmission is maintained due to an adaptive increase in the contribution of L-type channels to acetylcholine release (19) . The present study adds to this body of evidence demonstrating the ability of enteric neurons to offset the functional deficit in P/Q-type VGCCs in tg/tg mice. We presented electrophysiological evidence showing sustained inhibitory neuromuscular transmission in tg/tg mice due to increased contributions of L-type VGCCs. In addition we found that nitrergic neurotransmission can sustain muscle relaxation in the absence of the purinergic component of inhibitory neuromuscular transmission. This phenomenon has been called the "safety factor" for inhibitory neuromuscular transmission (67, 68) .
Potential mechanisms underlying increase in L-type VGCC function. Most of the studies providing evidence for functional upregulation of L-type VGCCs have not identified the underlying mechanism. Etheredge et al. (17) identified a compensatory contribution of L-type VGCCs to the whole cell current in basal forebrain neurons from tg/tg mice. They found that mRNA for other calcium channel subtypes did not increase in tg/tg mice, suggesting the upregulation of other VGCCs did not occur at the transcriptional level. A compensatory involvement of L-type channels in transmitter release from adult mammalian motor nerve terminals was identified after passive transfer of Lambert-Eaton plasma to mice. Lambert-Eaton human plasma contains antibodies directed to P/Q-type VGCCs causing disruption in the function and expression of these channels. However, the authors were unable to identify the mechanisms underlying this compensatory change in L-type function (19) .
Chronic stress induced an enhancement of the mRNA and protein expression of the ␣1C subunit of L-type channels (Cav1.2 channels) in the colonic muscle after 9 days (11). These changes depend on the release of norepinephrine from the adrenal medulla and are associated with faster colonic transit and increased defecation rate. The enhanced ␣1C expression is observed within 1 h after exposure to stress and thus transcriptional upregulation alone is not able to explain such a rapid increase in protein synthesis (39) . In this line, the authors were able to show that norepinephrine can rapidly increase ␣1C expression by diminishing degradation and increasing translation of existing ␣1C transcripts. These studies support the notion that L-type calcium channels are responsive to perturbations occurring within the enteric nervous system. In addition, these authors presented transcriptional and posttranscriptional modifications as a means to enhance expression of L-type channels without the necessity of de novo synthesis. However, according to the studies described above (11, 39 ) the plasticity of L-type calcium channels takes place at the postjunctional level and not at the motor nerve.
The present studies suggested that the observed plasticity of L-type channels occur at the level of the nerve because the muscle response to exogenous application of agonist of postjunctional transmitter targets is not altered in tg/tg mutant mice. Other investigators have shown that the ␣1C subunit (Cav1.2) of L-type VGCCs is expressed in the motor nerve fibers innervating the circular muscle cells and in myenteric neurons (32) . Whole cell recording of myenteric neurons from the guinea pig small intestine showed a 20% sensitivity of this current to block of L-type channels with nifedipine (2, 3). However, despite the fact that ␣1C channels are expressed in nerve varicosities there are no data supporting a role for ␣1C channels in neurotransmitter release under normal conditions.
The observed compensatory L-type channel contribution to inhibitory neuromuscular transmission to the colon of tg/tg mice could be due at least in part by an increased expression of this channel. This study presented data showing a significant enhancement in the function of L-type VGCC in tg/tg mice, but it cannot guarantee this change represents an increase in the expression or de novo synthesis of these channels. In addition, recruitment of existing L-type channels or a decrease in degradation of these channels could also contribute to the observed compensatory changes. Whether de novo synthesis or recruitment of existing L-type channels occur, the question that remains is How does the functional unmasking of L-type channels occur in tg/tg mice? One mechanism may be a reduction in the calcium-activated potassium channel (K Ca 2ϩ ) currents at the motor nerve terminals. This mechanism has been proposed to explain the compensatory involvement of L-type channels in synaptic transmission from motor nerve terminals after LEMS treatment (19, 20) . In this line, blocking of K Ca 2ϩ channels with iberiotoxin unmasked the contribution of L-type channels to acetylcholine release from normal mammalian motor nerve terminals (20) . Several studies have shown K Ca 2ϩ channels to be in close proximity to the VGCCs localized at nerve terminal active zones where they regulate transmitter release (53, 70) . Thus calcium influx through VGCCs can activate K Ca 2ϩ -generating K ϩ outflow and hyperpolarization. This hyperpolarization limits the duration of action potential-induced depolarization at the nerve terminal. The tg/tg mutation compromises the function of P/Q-type VGCCs reducing calcium current and thus activation of K Ca 2ϩ . Therefore, depolarization at the nerve terminal could be enhanced, allowing activation of L-type channels. L-type channels are most likely distantly located from the active zone. However, because calcium current flowing through L-type channels is large and long lasting it can reach the sites of neurotransmitter exocytosis.
Our data showing that the ENS can adapt to the loss of a key ion channel protein (P/Q-type calcium channel) are reminiscent of adaptations that occur in neuronal NOS (nNOS) gene KO mice (59) . CMMC frequency is controlled at least in part by NO released from myenteric neurons in WT mice. However, the CMMC frequency in the colon from constitutive nNOS KO mice is unchanged compared with the occurring in the colon from WT mice. Maintained CMMC frequency in the colon from nNOS KO mice was not altered by acute treatment with a NOS inhibitor, suggesting that other NOS isoforms were not upregulated in the colon of the nNOS KO mice (59) . Our data and those obtained in nNOS KO mice indicate that the ENS has the capacity to adapt to loss of key regulatory proteins and to maintain normal gut motility.
In conclusion, these studies show that enteric neurons have the capacity to adapt to deficiencies or mutations that cause the loss of function of a specific calcium channel subtype (P/Q channel in this case) function by upregulating other calcium channels. Upregulation of L-type calcium channels (normally expressed at low levels in the ENS) in enteric neurons of tg/tg mice supports normal motor function.
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